A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Saphenous Vein Graft Disease

Sex eligibility

All sexes

Study type

Observational

About this study

To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

CABG disease
randomized studies
not randomized studies

Exclusion criteria

studies reporting composite and not single endpoints, duplicate reporting

Treatment and study plan

Drug eluting stent

Device

pts with cabg disease treated with drug eluting stent

Other names: des

Bare Metal Stent

Device

pts with cabg disease treated with bare metal stent

Other names: bms

Primary outcomes

death

Time frame: years depending from studies retrieved

Secondary outcomes

myocardial infarction

Time frame: years depending from study retrieved
target vessel revascularization

Time frame: years depending from study retrieved

Sponsors and collaborators

Lead sponsor

Catholic University of the Sacred Heart

Other

Registry information

Official study title

Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis

Important dates

Study start: 2009
Primary completion: 2009
Study completion: 2009
First posted: Dec 21, 2009
Registry last updated: Dec 21, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed